Scholarlink

<p>Melanoma survival has improved nationally, yet state-level disparities remain underexplored. We assessed melanoma burden across U.S. states from 2010 to 2021 using Global Burden of Disease 2021 data, calculating age-standardized rates for incidence, prevalence, mortality, and disability-adjusted life years (DALYs). States were stratified by sociodemographic index (SDI). In 2021, the U.S. recorded 90,445 incident cases and 9996 deaths. Age-standardized incidence decreased 27.7% and mortality declined 24.9% from 2010 to 2021. Males showed 2.2-fold higher mortality than females. Incidence peaked in ages 85–89 (149.7/100,000); mortality was highest in those 95+ (33.3/100,000). Geographic disparities persisted with highest incidence in Utah, Colorado, and New Hampshire and lowest in District of Columbia and Mississippi. Despite similar incidence across SDI groups, low-SDI states had significantly higher mortality (2.23 vs. 1.86/100,000 in high-SDI states, <i>p</i> &lt; 0.05) and DALYs (69.6 vs. 57.0/100,000, <i>p</i> &lt; 0.05). While melanoma burden declined nationally, substantial disparities persist by sex, age, and geography. Low-SDI states experience worse outcomes despite comparable incidence, suggesting gaps in early detection and treatment access. Targeted interventions addressing both modifiable factors (screening, access) and regional risks are needed to reduce disparities.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Melanoma in the United States, 2010–2021: national trends and state-level patterns

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月20日

查看全文
  • Hossein Akbarialiabad,
  • Sancy A. Leachman,
  • Mohammad Hossein Taghrir,
  • Maryam Asgari,
  • Robert Dellavalle,
  • Jane M. Grant-Kels,
  • Seyed Mohammad Vahabi,
  • Alireza Abdshah,
  • Najmeh Sadeghian,
  • Rodrigo Valdes-Rodriguez,
  • Erin Scott Gardner,
  • Christopher G. Bunick,
  • Chante Aksut,
  • Hensin Tsao,
  • Ayman Grada

摘要

Melanoma survival has improved nationally, yet state-level disparities remain underexplored. We assessed melanoma burden across U.S. states from 2010 to 2021 using Global Burden of Disease 2021 data, calculating age-standardized rates for incidence, prevalence, mortality, and disability-adjusted life years (DALYs). States were stratified by sociodemographic index (SDI). In 2021, the U.S. recorded 90,445 incident cases and 9996 deaths. Age-standardized incidence decreased 27.7% and mortality declined 24.9% from 2010 to 2021. Males showed 2.2-fold higher mortality than females. Incidence peaked in ages 85–89 (149.7/100,000); mortality was highest in those 95+ (33.3/100,000). Geographic disparities persisted with highest incidence in Utah, Colorado, and New Hampshire and lowest in District of Columbia and Mississippi. Despite similar incidence across SDI groups, low-SDI states had significantly higher mortality (2.23 vs. 1.86/100,000 in high-SDI states, p < 0.05) and DALYs (69.6 vs. 57.0/100,000, p < 0.05). While melanoma burden declined nationally, substantial disparities persist by sex, age, and geography. Low-SDI states experience worse outcomes despite comparable incidence, suggesting gaps in early detection and treatment access. Targeted interventions addressing both modifiable factors (screening, access) and regional risks are needed to reduce disparities.